FHTX
Foghorn Therapeutics Inc
3.90$
-8.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Foghorn Therapeutics Inc (FHTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27 | -28 | -29 | -26 | -21 | -25 | -24 | -21 | -19 | -22 | -25 | -19 | -85 | |
| 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.2 | 0.2 | 2.2 | |
| 4.1 | 3.1 | 3.2 | 3.2 | 3.0 | 2.5 | 2.7 | 2.7 | 2.7 | 2.2 | 2.4 | 2.6 | 9.9 | |
| -18 | -8.2 | -9.3 | -9.7 | -5.2 | -8.1 | -9.3 | -7.7 | -6.9 | -8.2 | -8.2 | 7.1 | -16 | |
| 0.1 | 0.0 | 0.1 | 0.0 | 0.3 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | |
| 38 | 37 | 27 | -18 | -61 | 22 | 29 | 34 | 36 | 13 | -18 | -3.0 | 28 | |
| – | – | – | – | – | – | – | – | – | – | – | -50 | – | |
| 1.4 | 0.2 | 1.2 | 103 | 1.1 | 0.0 | 0.1 | 0.3 | 0.0 | 0.6 | 50 | -50 | 0.6 | |
| 13 | 10 | -1.1 | 60 | -81 | -2.2 | 5.6 | 13 | 17 | -8.5 | 6.8 | -72 | -57 | |
| -27 | -28 | -29 | -26 | -21 | -25 | -24 | -21 | -19 | -22 | -25 | -19 | -85 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.